Please assess the completion status of the following clinical trial:

Trial Title: Anesthesia and Lymphocytes Apoptosis

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* male adults~* aged 18-80 yr~* undergoing elective OPCAB surgery containing left anterior descending artery bypass~Exclusion Criteria:~* a previous unusual response to any of the experimental anesthetics~* severe cardiac dysrhythmias or ejection fraction below 30%~* hemodynamic instability~* previous surgical coronary artery repair~* anemia, abnormal leukocytes or coagulopathy~* severe hypertension~* severe hepatic (albumin\<30g,ascites), renal (serum creatinine greater than 2.0 mg/dl) or pulmonary (preoperative pulmonary function tests moderate-severe) dysfunctions~* concomitant surgical procedures and psychiatric disorders~* Insulin-dependent diabetics

- Gender: MALE
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- Sevoflurane (Type: EXPERIMENTAL): None
- Propofol (Type: EXPERIMENTAL): None
- Combine of sevoflurane and propofol (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).